A crosswalk tabular review on methods and outcomes from randomized clinical trials using pathogen reduced platelets
- 23 April 2020
- journal article
- review article
- Published by Wiley in Transfusion
- Vol. 60 (6), 1267-1277
- https://doi.org/10.1111/trf.15791
Abstract
No abstract availableThis publication has 23 references indexed in Scilit:
- A pilot study to assess the hemostatic function of pathogen‐reduced platelets in patients with thrombocytopeniaTransfusion, 2012
- A multi‐centre study of therapeutic efficacy and safety of platelet components treated with amotosalen and ultraviolet A pathogen inactivation stored for 6 or 7 d prior to transfusionBritish Journal of Haematology, 2011
- A randomized controlled clinical trial evaluating the performance and safety of platelets treated with MIRASOL pathogen reduction technologyTransfusion, 2010
- Clinical effectiveness of leucoreduced, pooled donor platelet concentrates, stored in plasma or additive solution with and without pathogen reductionBritish Journal of Haematology, 2010
- Platelets photochemically treated with amotosalen HCl and ultraviolet A light correct prolonged bleeding times in patients with thrombocytopeniaTransfusion, 2006
- Transfusion of 7‐day‐old amotosalen photochemically treated buffy‐coat platelets to patients with thrombocytopenia: a pilot studyTransfusion, 2006
- Recovery and life span of 111indium‐radiolabeled platelets treated with pathogen inactivation with amotosalen HCl (S‐59) and ultraviolet A lightTransfusion, 2004
- Therapeutic efficacy and safety of platelets treated with a photochemical process for pathogen inactivation: the SPRINT TrialBlood, 2004
- Transfusion of pooled buffy coat platelet components prepared with photochemical pathogen inactivation treatment: the euroSPRITE trialBlood, 2002
- How do patients' treatment preferences compare with those of clinicians?Quality and Safety in Health Care, 2001